Market cap
$58 Mln
Revenue (TTM)
$18 Mln
P/E Ratio
--
P/B Ratio
1.5
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$0 Mln
-
ROE
-0.3 %
-
ROCE
-- %
-
Industry P/E
44.46
-
EV/EBITDA
8.7
-
Debt to Equity
0
-
Book Value
$--
-
EPS
$-0.9
-
Face value
--
-
Shares outstanding
16,462,059
10 Years Aggregate
CFO
$-22.06 Mln
EBITDA
$-0.45 Mln
Net Profit
$12.96 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Sensus Healthcare (SRTS)
| -18.2 | 11.9 | 14.2 | -4.0 | 1.4 | -1.9 | -6.4 |
|
BSE Sensex
| -9.6 | -2.0 | 3.1 | -4.7 | 5.4 | 6.0 | 10.4 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Sensus Healthcare (SRTS)
| -42.5 | 190.7 | -68.2 | 2.8 | 87.0 | 9.0 | -52.2 |
|
S&P Small-Cap 600
| 4.0 | 7.0 | 13.9 | -17.4 | 25.3 | 9.6 | 20.9 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 | 4.4 | 22.0 | 15.8 | 14.4 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Sensus Healthcare (SRTS)
|
3.3 | 58.0 | 17.5 | -15.5 | -56.5 | -36.5 | -- | 1.5 |
| 60.2 | 8,018.1 | 616.9 | -75.1 | 1.7 | -9.3 | -- | 10.2 | |
| 14.6 | 9,638.1 | 6,561.1 | -578.0 | -4.5 | -10.3 | -- | 1.7 | |
| 365.1 | 9,761.6 | 2,589.3 | 222.4 | -6.0 | 3 | 44.5 | 1.3 | |
| 58.4 | 8,696.7 | 3,499.6 | -71.2 | 0.5 | -3.2 | -- | 3.8 | |
| 179.0 | 10,905.5 | 612.8 | -188.1 | -30.6 | -28.1 | -- | 16.4 | |
| 100.9 | 6,577.5 | 1,556.3 | 275.3 | 24.6 | 22.9 | 24.1 | 5.0 | |
| 91.0 | 5,403.2 | 1,579.2 | 145.6 | 14.3 | 8.9 | 37.2 | 3.2 | |
| 324.2 | 12,752.7 | 1,504.9 | 160.6 | 13.6 | 10.9 | 79.4 | 8.4 | |
| 172.3 | 9,947.9 | 785.1 | 41.5 | 9.9 | 2 | 251.8 | 4.9 |
Shareholding Pattern
View DetailsAbout Sensus Healthcare (SRTS)
Sensus Healthcare, Inc. operates as a medical device company that manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy, a low-energy X-ray technology in its portfolio of... treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which provides the user with a superficial radiation therapy-tailored treatment planning application that integrates an embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. The company also provides SRT-100 +; Sentinel service program, which offers its customers protection for their systems; and Transdermal Infusion system, a biophysical alternative to infuse high weight molecule modalities into the dermis for medical and aesthetic purposes without the use of needles. In addition, it sells disposable lead shielding replacements; and disposable radiation safety items, such as aprons and eye shields, ultrasound probe film, and disposable applicator tips to treat various sized lesions and various areas of the body. Further, the company distributes laser devices, such as applications for hair removal, vascular lesions, acne treatment, skin toning, and skin rejuvenation, as well as epidermal pigment removal for spots, freckles, and tattoos, as well as provide operational healthcare services for dermatology clinics. It markets its products primarily to private dermatology practices, and radiation oncologists in both private and hospital settings. The company was incorporated in 2010 and is based in Boca Raton, Florida. Read more
-
Co-Founder, Chairman & CEO
Mr. Joseph C. Sardano
-
Co-Founder, Chairman & CEO
Mr. Joseph C. Sardano
-
Headquarters
Boca Raton, FL
-
Website
FAQs for Sensus Healthcare (SRTS)
What is the current share price of Sensus Healthcare Inc (SRTS) Today?
The share price of Sensus Healthcare Inc (SRTS) is $3.26 (NASDAQ) as of 02-Sep-2026 12:30 EDT. Sensus Healthcare Inc (SRTS) has given a return of 1.42% in the last 3 years.
What is the current PB & PE ratio of Sensus Healthcare Inc (SRTS)?
Since, TTM earnings of Sensus Healthcare Inc (SRTS) is negative, P/E ratio is not available.
The P/B ratio of Sensus Healthcare Inc (SRTS) is 1.52 times as on 28-Aug-2026, a 60 discount to its peers’ median range of 3.79 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2025 |
-8.42 |
1.35 |
2024 |
17.12 |
2.04 |
2023 |
79.17 |
0.79 |
2022 |
5.07 |
2.56 |
2021 |
29.10 |
4.61 |
What is the 52 Week High and Low of Sensus Healthcare Inc (SRTS)?
The 52-week high and low of Sensus Healthcare Inc (SRTS) are Rs 5.49 and Rs 2.66 as of 02-Sep-2026.
What is the market cap of Sensus Healthcare Inc (SRTS)?
Sensus Healthcare Inc (SRTS) has a market capitalisation of $ 58 Mln as on 28-Aug-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Sensus Healthcare Inc (SRTS)?
Before investing in Sensus Healthcare Inc (SRTS), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.